Trial offering new treatment combination for melanoma brain metastases opens at Alfred Health

by Biotech Newsroom


Congratulations to Dr. Malaka Ameratunga and the team at Alfred Hospital on the activation of the BETTER trial!

The BETTER trial, sponsored by Monash is testing a new treatment combination for melanoma that has spread to the brain, with the goal of improving outcomes for patients facing a poor prognosis and life expectancy. The trial will evaluate the safety and efficacy of the treatment combination, potentially offering new hope for those with advanced melanoma. 

“Melanoma brain metastasis is so severe and complex that many patients are…



Source link

You may also like

Houston, TX – (EmailWire) — The Biotech Times™ aggregates, publishes and distributes news about the Biotech Industry. In association with EmailWire™, The Biotech Times, helps businesses and organizations in the industry with press release distribution. Press releases are disseminated to journalists, experts, investors, trade publications and other related media outlets. For more information, contact us through the following messaging apps:

Free Magazines

Recent Articles

BioTech Times™ is part of GroupWeb Media Network. © 2026 GroupWeb Media LLC